Zeng Francine, Mallozzi Scott, Moss Isaac, Cote Mark, Sakalkale Durgadas
University of Connecticut School of Medicine, Farmington, CT, USA.
Department of Orthopaedic Surgery, University of Connecticut Health Center, Farmington, CT, USA.
Interv Pain Med. 2022 Jan 26;1(1):100066. doi: 10.1016/j.inpm.2022.100066. eCollection 2022 Mar.
The goal of this study is to assess the clinical effectiveness and prognostic potential of simultaneous bilateral lumbar transforaminal epidural steroid injections (TFESIs) in patients with bilateral radicular back pain with previous history of lumbar laminectomy and/or fusion surgery.
Retrospective case series.
Single physiatrist in an academic setting.
23 patients with previous lumbar surgery who received bilateral TFESIs.
Cumulative bilateral radicular back pain was assessed with a pain numerical rating scale (NRS, 0-10) prior to receiving bilateral TFESI and at minimum 2 weeks follow-up. Responders included patients who experienced any NRS pain reduction post-procedure and non-responders were patients who reported no change in pain. A minimal clinically important difference (MCID) was defined as NRS change ≥2.0 to identify the proportion of responders who experienced a clinically significant reduction in pain. Other outcome measures included subsequent repeat bilateral TFESI, operations at the level of injections, and operative outcomes of these patients.
There was a statistically significant (P < 0.0001) reduction of 2.2 in mean NRS at average 3.7 weeks follow-up. With the MCID defined as NRS pain reduction ≥2, 13 of 16 responders (56%; CI 36.8-74.4%) achieved a clinically significant reduction in pain. Nine patients (39.1%) went on to receive repeat bilateral TFESIs and 9 patients (39.1%) underwent surgical interventions involving the same spinal level as the injections. Eight of the 9 patients who underwent repeat bilateral TFESIs met follow-up criteria and each responded to repeat injections with an average NRS pain reduction of 2.2. Of the 9 surgical patients, 5 responded to the previous injections and each reported improvements in pain and function after their operations (PPV = 100%). Of the 4 surgical patients who were non-responders to the injections, 2 reported improvements in pain and function post-operatively and the remaining 2 reported no change or worsening outcomes (NPV = 50%).
This study suggests bilateral TFESIs are clinically effective in short-term management of bilateral radicular back pain in patients with previous lumbar surgery, and they reveal potential prognostic information for subsequent surgical intervention.
本研究的目的是评估双侧经椎间孔硬膜外类固醇注射(TFESI)对有双侧神经根性背痛且既往有腰椎椎板切除术和/或融合手术史患者的临床疗效和预后潜力。
回顾性病例系列研究。
学术环境中的单一物理治疗师诊所。
23例既往接受过腰椎手术且接受双侧TFESI治疗的患者。
在接受双侧TFESI治疗前及至少2周随访时,采用疼痛数字评分量表(NRS,0 - 10)评估双侧累积神经根性背痛。有反应者包括术后NRS疼痛评分降低的患者,无反应者为报告疼痛无变化的患者。最小临床重要差异(MCID)定义为NRS变化≥2.0,以确定疼痛有临床显著减轻的有反应者比例。其他结局指标包括随后重复进行双侧TFESI、注射部位的手术以及这些患者的手术结局。
在平均3.7周的随访中,平均NRS评分有统计学显著降低(P < 0.0001),降低了2.2分。将MCID定义为NRS疼痛评分降低≥2时,16例有反应者中的13例(56%;可信区间36.8 - 74.4%)疼痛有临床显著减轻。9例患者(39.1%)继续接受重复双侧TFESI治疗,9例患者(39.1%)接受了与注射部位相同脊柱节段的手术干预。9例接受重复双侧TFESI治疗的患者中有8例符合随访标准,且每次重复注射后平均NRS疼痛评分降低2.2分。9例手术患者中,5例对之前的注射有反应,且每例患者术后疼痛和功能均有改善(阳性预测值 = 100%)。4例对注射无反应的手术患者中,2例术后疼痛和功能有改善,其余2例报告无变化或结局恶化(阴性预测值 = 50%)。
本研究表明双侧TFESI对既往有腰椎手术史的患者双侧神经根性背痛的短期治疗具有临床疗效,并且揭示了后续手术干预的潜在预后信息。